title: Lithium augmentation in milnacipran-refractory depression for the prevention of relapse following electroconvulsive therapy.
authors.forename: Hideki
authors.initials: H
authors.lastname: Okamoto
authors.forename: Eiji
authors.initials: E
authors.lastname: Shimizu
authors.forename: Kimiyoshi
authors.initials: K
authors.lastname: Ozawa
authors.forename: Kenji
authors.initials: K
authors.lastname: Hashimoto
authors.forename: Masaomi
authors.initials: M
authors.lastname: Iyo
mesh_terms: D000928:Antidepressive Agents / Q000008:administration & dosage*; D003521:Cyclopropanes / Q000008:administration & dosage*; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016651:Lithium Carbonate / Q000008:administration & dosage*; D008875:Middle Aged; D000078764:Milnacipran; D055502:Secondary Prevention
chemical_list: D000928:Antidepressive Agents; D003521:Cyclopropanes; D016651:Lithium Carbonate; D000078764:Milnacipran